Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological Standardization of Alternaria Alternata Allergen Extract
NCT01984528Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Feb 2014
- Primary completion
- Nov 2014
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of alternaria alternata allergen extract in Alternaria alternata allergy, sponsored by LETI Pharma. Started Feb 2014; status: completed.
02
Drugs
alternaria alternata allergen extract
03
Conditions
Alternaria alternata allergy
Beyond the preview
Go deeper on NCT01984528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01984528.